comparemela.com

Latest Breaking News On - Lifetech scientific corporation stock code - Page 1 : comparemela.com

LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development -April 02, 2024 at 10:12 am EDT

SHENZHEN, China, April 2, 2024 /PRNewswire/ LifeTech Scientific Corporation , a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and.

United statesInternational business achieved robust growthAortic branch stent graft systemLifetech scientific corporationRobust growth of international businessBiotyx medical shenzhen co ltdFinancing facilitating the developmentLifetech scientific corporation stock codeAortic arch branch stent graft systemNational medical products administrationAbsorbable material technology platformTech scientific corporationInternational businessReporting periodCash flow positionBiotyx medical

LifeTech Scientific Corporation (1302 HK) Announces 2023 Interim Results

SHENZHEN, China , Aug. 30, 2023 /PRNewswire/ LifeTech Scientific Corporation , a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and.

National medical products administrationLifetech scientific corporation stock codeProgress of researchAortic arch branch stent graft systemAortic branch stent graft systemLifetech scientific corporationTech scientific corporationMain businessThoracic aortic aneursyAbdominal aortic aneursyIliac artery bifurcationVena cava filterSizing balloonSuper stiff guidewireSnare systemMedical device regulation

LifeTech Reports Steady Growth of 32 5percent in Net Profit Attributable to Owners of the Company in 2022

SHENZHEN, China, March 29, 2023 /PRNewswire/ LifeTech Scientific Corporation , a leading company specialized in minimally invasive interventional medical devices for. | March 29, 2023

United statesDrug administration for compassionateLifetech scientific corporation stock codeMinistry of foodAortic arch branch stent graft systemNational medical products administrationLifetech scientific corporation the company orShowa university hospitalAortic branch stent graft systemLifetech scientific corporationAdult congenital heart disease centerLeft atrial appendageCongenital heart diseasesVena cava filter systemBalloon dilatation catheterStent graft system

LifeTech Reports Steady Growth of 32 5percent in Net Profit Attributable to Owners of the Company in 2022

SHENZHEN, China, March 29, 2023 /PRNewswire/ LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results. During the year ended 31 December 2022, Lifetech achieved a revenue of approximately RMB1,097.3 million, increased by 18.6% year on year. The.

United statesAortic branch stent graft systemAortic arch branch stent graft systemAdult congenital heart disease centerLifetech scientific corporationMinistry of foodLifetech scientific corporation stock codeNational medical products administrationDrug administration for compassionateShowa university hospitalLifetech scientific corporation the company orLeft atrial appendageCongenital heart diseasesVena cava filter systemBalloon dilatation catheterStent graft system

vimarsana © 2020. All Rights Reserved.